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Experience with 150 Liver Resections 
SHUNZABURO IWATSUKI, M.D., BYERS W. SHAW, JR., M.D., THOMAS E. STARZL, M.D., PH.D. 
One hundred fifty liver resections were performed with an op-
erative mortality rate of 4%. Indications for liver resections 
were 43 primary liver malignancies, 43 metastatic liver tumors, 
and 64 benign liver diseases. The 3-year actuarial survival rate 
after treatment of primary liver malignancy was 56%, and that 
after treatment of metastatic liver tumors was 66%. All but 
one of 59 patients with benign disease who survived operation 
were alive without development of late symptoms or compli-
cations. 
D URING A 17-year period, from October 1964 to March 1982, 150 subtotal liver resections were 
performed by the liver transplantation surgeons at the 
University of Colorado Health Sciences Center and the 
University Health Center of Pittsburgh, Pennsylvania. 
This report emphasizes the low mortality and morbidity 
rates after liver resections, the encouraging survival rates 
of patients with both primary and metastatic malignant 
disease, and the value of hepatic resection in treating 
patients with nonmalignant hepatic lesions. 
Methods 
Case Material 
The medical records of all 150 patients who under-
went resection of a portion of the liver for treatment 
were reviewed. It was possible to trace every patient, and 
for those still living, the follow-up was to May 1982. 
Portions of the authors' past experience have been re-
ported earlier. 1-6 
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The patients ranged in age from 11 months to 77 
years. Fourteen of the 150 patients were infants or chil-
dren ranging in age from 1 1 months to 16 years. Twelve 
of the 14 had malignant diseases. Sex distribution in 
patients with malignant diseases was equal, both with 
primary and metastatic neoplasms. For adenomas and 
focal nodular hyperplasias, female predominance was 
observed. 
The number ofliver resections has increased sharply 
through the years (Table 1). During the -last 12 months, 
42 liver resections were performed at the University 
Health Center of Pittsburgh. Indications for liver resec-
tions are listed in Table 2. Eighty-six patients had ma-
lignant diseases of which 43 were primary to the liver. 
The liver tumors in the 43 patients with resectable met-
astatic neoplasms were of various origins (Table 2). The 
64 patients with benign liver diseases underwent liver 
resections for therapeutic purposes or because malig-
nancy was suspected. 
The patients with benign disease often had acute and 
life-threatening complications, including the three with 
hepatic trauma. Three patients with cavernous heman-
gioma had spontaneous hemorrhage, and two more had 
emergency resection for bleeding after unwise needle 
biopsies. Five of the patients with adenomas had resec-
tions after the tumors had ruptured. Four patients clas-
sified in the benign group had multiple adenomatosis 
in all segments of the liver with massive hepatomegaly; 
complications, singly or in combination, included pain, 
disabling pressure symptoms, or hemorrhage. One year 
after resection one of these four patients required liver 
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TABLE I. Incidence of Liver Resection by Five-Year 
Period and Indication 
Number Indications 
of Liver 
Resections Malignant Diseases Benign Diseases 
1964-1970 6 2 4 
1971-1975 25 16 9 
1976-1980 78 45 33 
1981- 41 23 18 
Total 150 86 64 
transplantation when the remaining left lateral segment 
refilled with rapidly growing adenomas. One patient 
with polycystic disease was treated with right trisegmen-
tectomy because of debilitating pressure symptoms that 
had necessitated intravenous hyperalimentation for six 
weeks. 
TABLE 2. Indications for 150 Liver Resections 
Malignant Diseases 
Primary malignant neoplasms 
Hepatoma 
Squamous cell carcinoma of cyst wall 
Hepatoblastoma 
Cholangiocarcinoma 
Rhabdomyosarcoma 
Leiomyosarcoma 
Angiosarcoma 
Sarcoma, undetermined cell type 
Cholangiocarcinoma of bile duct 
Adenocarcinoma of gall bladder 
Metastatic Neoplasms 
Colorectal adenocarcinoma 
Carcinoid tumor 
Adrenocortical carcinoma 
Wilm's tumor 
Adenocarcinoma of kidney 
Spindle cell sa.rcoma of intestine 
Leiomyosarcoma of stomach 
Glucagonoma 
Neuroblastoma of adrenal 
Melanoma of eye 
Hemangiosarcoma of breast 
Medullary carcinoma of thyroid 
Squamous cell carcinoma of endocervix 
Ovarian carcinoma 
Benign Diseases 
Hemangioma 
Adenoma 
Cysts: 
simple 4 
polycystic 2 
Focal nodular hyperplasia 
Trauma 
Abscess 
Fibroma 
Leiomyoma 
Regenerative nodule 
Total 
43 cases 
29 
3 
2 
2 
2 
I 
1 
I 
1 
1 
43 cases 
24 
3 
3 
2 
2 
1 
1 
1 
1 
1 
1 
1 
1 
1 
64 cases 
32 
14 
7 
4 
3 
1 
1 
1 
1 
150 
Operative Procedures 
The principles of anatomic liver resection have been 
described previously with emphasis on right trisegmen-
tectomy l.2 and left trisegmentectomy.5 In most cases, a 
bilateral subcostal incision was used with an upper mid-
line extension through which the xiphoid process was 
exercised. A thoracic extension was not made unless the 
need for additional exposure became evident after the 
lesion was assessed. Nonanatomical resections of the 
liver were classified as local excisions, even though some 
of these were extremely complex procedures. Diagnostic 
or therapeutic wedge resections were not considered 
hepatic resections. 
Complete hemostasis was considered the most im-
portant factor in preventing postoperative complica-
tions. Bile leakage was carefully searched for. Intra-
operative cholangiography was often used to identify the 
source of bile leak and duct kinking. A T-tube or U-
tube was used to stent the repair of the bile ducts when 
these required major reconstruction. The surgical area 
drained with multiple Penrose drains or with closed suc-
tion drainage catheters. 
The anatomic resections used (Table 3) were right 
lobectomy, left lobectomy, left lateral segmentectomy, 
right trisegmentectomy, and left trisegmentectomy. The 
right trisegmentectomy involved removal of the true 
right lobe and the median segment of the left lobe. 1•2 
Left trisegmentectomy meant removal of the true left 
lobe plus the anterior segment of the right lobe.5 The 
fact that 68 of the 150 resections were right or left tri-
segmentectomies reflected the highly screened nature of 
the case material. Many of the patients were referred by 
surgeons who had determined at a preliminary operation 
that an unusually extensive procedure would be neces-
sary. 
Six of the right hepatic trisegmentectomies for me-
tastases and one right lobectomy were performed at the 
same time as resection of the primary tumor. In six of 
the seven patients, the primary neoplasm was in the right 
adrenal gland (four examples) or right kidney (two ex-
amples), necessitating adrenalectomy in continuity in 
all six and right nephrectomy in four. The seventh pa-
tient had a discontinuous right colectomy for adeno-
carcinoma of the cecum. 
Each variety of the anatomical resections was used 
for at least one patient with benign disease. There were 
18 examples of right lobectomy for benign disease. Right 
trisegmentectomy was used 14 times to remove a non-
malignant lesion (Table 3). 
Adjuvant Therapy 
When used, adjuvant therapy was begun after recov-
ery from the surgical procedure seemed assured, one to 
several weeks after operation. Twenty-eight of the 43 
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patients with primary hepatic malignancy were given <l) 
'-;>'" 
chemotherapy, and five received local irradiation. ::: C:Db~ 011 1 01 1 1 1 1 1 1 0 0 ~ C~ Twenty-two of the 43 patients with metastatic liver tu- '<;1 
·c 0 
mors were given chemotherapy, and six received local >< "'-l 
irradiation. The remaining patients did not receive ad- «i u 
.... juvant therapy either because they declined such treat- .3 0 <Ii MIN- ~f~- NMON on 
ment or because they were considered too frail. Some 00. 1"1 Z 
who are still early postoperative may become candidates 
for later chemotherapy. 0) 
.... ;.'" 
The most common treatment for primary liver ma- ;., ~K~~ 1 I 01 I I 1 I 1 I 0 _ E 01 lignancy2 was 5-tluorouracil, cyclophosphamide and e!S ~ C~ 
<l) U 0 
vincristine, which was followed by adriamycin, if nec- ~~ .,; 
essary, for recurrences. In the last few years these four <l) a 
"" 
j~ '- .;: 
drugs have been administered simultaneously rather <l) 0 <Ii .... 0: 0\1 M-C 
.".IM 1 
-I 1 1 M 
.S: CI) 00. 0 than holding adriamycin for recurrences. More recently B Z ~ <l) 
the combination of mytomycin and 5-tluorouracil has «i ~ ~ ~ been administered in some patients. For colorectal me- OIl c <l) ~ 
'" 
'- ;> '" 
tastases, 5-tluorouracil has been the most commonly ..... ;., ~K~ ~ I 1 1 1 1 1 1 1 ::: ..... a 01 01 0 0 
used agent. 2 ~ C~ .;: ~ 0 u t) 0 ~ 
'- ~ <l) Results ~ ... 
.3 ... ::::: <l) 
<:S .... 1: Operative Mortality 1:: j 0 ~ .!1 001 on M onl - - 11"1- 1 M ... ~pK .s 
Any death within 30 days after liver resection as well 
'" 
::: ,. K~ as any death during the initial hospitalization for liver K~ 
resection, regardless of time, was counted as an operative '" <l) ti K~ a- '- ;> '" 3 o '';:: ..c:: 
mortality. There were six deaths among 150 liver resec- ;., op~ I I I I I on '@. 
"'" 
E ~ ::: S Z &-0 0 tions, for an overall operative mortality of 4.0% (Table <:S -1- -I 1"1 ..c: 0: u 0 
3). Details of the mortality after various kinds of resec- s: ~ ] 8 0 tion are given in Table 3. These are right lobectomy, ...l :§ ~ ~ '-0 <l) 6.5%; left lobectomy, 0%; right trisegmentectomy, 6.3%; ~ <Ii :;1 on 00 ~f OO-C 1-1"1- .s 00.. M 
'" Z OIl left trisegmentectomy, 0%; left lateral segmentectomy, .!::: ::: 
ot '1: 0%; local excision, 0%. The mortality after resection for ::I 
.S: -0 
benign and malignant disease, respectively, was two out B 0) ..c: ;., .... ;>'" ~ 
of 64 (3.1 %) and four out of 86 (4.7%). «i E ~K~~ 1 1 1 1 1 1 1 1 0) ~ 01 01 0 -0 0 ~ C~ .... t) ;., The circumstances of the deaths are summarized in 
'" 
<l) 0 ::: ,. ~~ ~ Table 4. The only patient in whom hepatic failure was ;::j '" ...lOJ ~
',& E :n not a factor was a 50-year-old man who died intra- OIl s:: <l) .... ~ '" 0 <Ii 
operatively as the result of incorrect placement of a cen- '" '1: MIN- -1- I I I I I .". '" ~ f- 00. ~tral venous catheter. Four of the six deaths were of pa- Z '" ;., M ~ 
tients who had pre-existing cirrhosis, and in one ofthese -0 ~ 0 
....l 
cases the performance of a resection for a huge and single o:l 0) ti M -< ;., .... ;>'" ::: f- a ~K~ ~ I I I I M :E hyperplastic nodule represented an error both in diag- ~ ~ C~ ~ K~ 
nosis and judgement. Two other patients who died OJ 0 MIM 01 .". 
...;'E ~ (Cases 3 and 4 in Table 4) had a history of chronic ~ <l) E OJ 
-0 
alcoholism, although their livers were not grossly cir- OIl .... ~ ;., 0 ::: 
rhotie. '1: dE. ~f~~ ::!:I on-c --I- v ~ f- -c 
'" Z ~Six of the 150 patients who underwent hepatic resec- '" OJ
tion had significant underlying cirrhosis. Three of these ::: ...: 0) 
patients died from hepatic failure after operation, ac- '" -0 OJ ..c: 
'" .... ~ counting for one half of the total operative mortality. ~ V} d ~ ~ ~ ~ E "RD~ 0) i5 -0 U ~ K~ ~"U e- O) 
E c'B .- ::: E Z ~ ;> Surgical Complications ~ ~ "' Q ~o_C"Ia~ K~ ::: E.l9 ::: a~e;"~::fll & Three of the 150 patients required re-exploration for 01)'1: OJ .!!P ~ -0 o..c: ;., e! 0 3 ~ Q.. ~ ~ <~ Uf- o 0 
postoperative bleeding. The hemorrhage that was from ~ ll:l f-
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TABLE 4. Time and Calise 0/ Operative J40rlalily 
Case 
2 
3 
4 
5 
6 
Original diagnosis 
Hepatoma* 
Hepatoma in cirrhotic 
(thorotrast) liver 
Infected hepatoma 
Hepatoma 
Hepatoma in cirrhotic 
liver 
Ruptured hepatoma 
in cirrhotic liver 
Final Diagnosis 
Same 
Same 
Fungal and bacterial 
abscess; thrombosis 
intrahepatic portal 
and hepatic veins 
Same 
Same 
Giant regenerative 
nodule in cirrhotic 
liver 
* Case previously reported.2 A reversed vena caval graft had been 
used to drain residual lateral segment after remaining left hepatic vein 
had been resected. 
the raw liver surface was controlled, but the patient 
whose resection was for a giant hyperplastic nodule died 
subsequently of hepatic insufficiency. Twelve patients 
had abscesses form in the right subphrenic space. In six 
instances the pus collections were drained by reopening 
anterior drain tracts that had closed prematurely at or 
near the body wall. Six abscesses were drained posteri-
orly by removing the right twelfth rib. In six other pa-
tients, posterior drainage procedures were carried out 
in the early postoperative period because of difficulty in 
effectively irrigating deeply placed cavities from the an-
terior approach. The complications occurred almost 
uniformly after right trisegmentectomy. 
Major bile leaks occurred after two right and two left 
trisegmentectomies. In each instance a portion of the 
bile duct to the residual segment had been involved with 
tumor and had been resected. The bile ducts had been 
reconstructed over a T-tube or V-tube stents. In each 
instance, the bile leaks ceased spontaneously without 
further operative intervention. Minor bile leaks through 
the drain site were seen commonly, but these all closed 
spontaneously within a few days. One patient each had 
bile duct obstruction several months after right triseg-
mentectomy and left lobectomy. The etiology was re-
current tumor. In the patients with left lobectomy, the 
obstruction was distal and was relieved by anastomosing 
the uninvolved proximal common duct to a Roux-en-
Y jejunal loop. 
Two patients had major gastrointestinal hemorrhage 
after right trisegmentectomy, and both died (Table 4). 
Time of 
survival 
Procedure (days) 
RTS 20 
RTS 58 
RTS 32 
RTS 45 
RL o 
RT 4 
RTS: right trisementectomy. 
RL: right lobectomy. 
Cause of Death 
Hepatic failure; thrombosis 
coeliac axis 
Hepatic failure; pulmonary 
metastases 
Hepatic failure; stress ulcer 
hemorrhage 
Hepatic failure; stress ulcer 
hemorrhage 
Unrecognized perforation of 
central venous catheter into 
mediastinum; hypovolemia 
and mediastinal tamponade. 
Hepatic failure 
Another patient developed small bowel obstruction two 
weeks after right hepatic lobectomy. The problem was 
rectified by lysis of the responsible adhesions. 
Long-term Follow-up 
The 62 patients with benign disease who survived 
operation were alive in May 1982. With one exception 
none had developed late complications. The exceptional 
patient was the one who developed hepatic adenoma-
tosis in the residual lateral segment after right triseg-
mentectomy. She was treated with orthotopic liver trans-
plantation after which she promptly recovered. 
The actuarial survival of patients with hepatic malig-
nancies is shown graphically in Figures 1 and 2. Stan-
dard errors became greater than 10% after three years. 
The 3-year actuarial survival in patients with primary 
hepatic malignancy was 56% and with metastatic liver 
neoplasms, the survival was 66%. The survival up to five 
years was not statistically significant between those with 
primary and metastatic liver neoplasms, nor were there 
significant differences in the subgroups of either of these 
two major categories. Actuarial survival five years after 
liver resection for primary hepatic tumors was 46% and 
for metastatic neoplasms, it was 57%. 
Discussion 
The low mortality and morbidity after liver resection 
in these 150 cases have made the authors willing to at-
tempt such operations in increasing numbers of patients 
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with benign and malignant hepatic lesions. The death 
rate of 4% within the first 30 days or at any time during 
the hospitalization has compared favorably with that in 
other large series listed in Table 5.7- 24 Most of the deaths 
in this series were of patients with pre-existing cirrhosis 
and/or a history of chronic alcoholism, and in all but 
one case hepatic insufficiency was responsible for the 
fatal evolution. Because the surgical principles of hepatic 
resection are so well standardized, 1.2.5 skillful anesthetic 
management has become the single most important fac-
tor in maintaining an acceptable operative mortality. 
Gifted anesthesiologists at two institutions have been 
able over a period of 17 years to cope with the acute 
blood loss and the intraoperative metabolic and cardio-
vascular instability that was often seen at the time of 
parenchymal transection. 
In the long history of liver resection, two principal 
causes of peri operative death have been hemorrhage and 
infection. Postoperative hemorrhage requiring reopera-
tion was reduced to 2% in this series. However, sub-
phrenic or subhepatic abscesses required operative relief 
in 12 (8%) of the patients, of whom nine and three, 
respectively, had right trisegmentectomy and right lo-
bectomy. This complication was not surprising in view 
of the large right subphrenic dead space created by major 
right hepatic resections. Previously, the authors rec-
ommended broad open drainage of this space at the time 
of resection usually by leaving open a part of the inci-
sion.' More recently, closed drainage techniques have 
been used. The incidence of the infections has been 
about the same with both methods. The recognition and 
localization of the abscesses has been greatly simplified 
by ultrasonography and computerized axial tomogra-
phy. Secondary drainage by an anterior or posterior ap-
proach, or by both with a through and through com-
munication was always successful. 
The fact that all but one of the surviving patients with 
benign disease were cured of their problems was to be 
expected and was consonant with the numerous reports 
in the literature. However, the true value of major he-
patic resection for primary or metastatic liver disease 
often has been questioned. Long-term survival data have 
been given in only a handful of reports (Table 5). 
The best data have been for primary hepatic malig-
nancies. In Foster's collection 296 patients with primary 
liver cancer from the pre-1970 literature, the 2- and 5-
year determinant survival rates were 33.3% and 14% 
overall, but they were 59% and 36% for nonAsian, and 
23% and 6% in Asian patients.7 There were four large 
Asian series reported in English literature since Fosters' 
review in 1970. Lin from Taiwan reported 3-year and 
5-year actual survival of 20% and 19% in 1976.10 Lee, 
Wong. and Ong from Hong Kong reported one- and 
three-year actuarial survival. respectively, of 45% and 
100% 
80 
60 
40 
20 
()--{) Primary (n=43) 
x-x Metastatic (n=43) 
liKKKKi-f---i--KKKKKKfKKK--KKKKfKKK---~--g 
~~ 1Y 2Y 3Y 4Y 5Y 
FIG. 1. Actuarial survival after liver resection. Comparison between 
primary liver malignancies and metastatic liver tumors. There are no 
statistically significant differences between the two at any point oftime. 
20%." Balasegaram and Joishy from Malaysia reported 
a possible survival of 58.5% and 43.6(1'0 at one and three 
years after liver resection; 12.13 however, survival rates 
Hepatoma, 
0--0 Hepatoblastoma (n=32) 
100% x-x Colon Ca Mets (n=24) 
80 
60 
---:x 
40 
20 
OL....L-I----'-__ ......I... __ ..I.-_---J'---_-J 
~~ 1Y 2Y 3Y 4Y 5Y 
FIG. 2. Actuarial survival after liver resection. Comparison between 
hepatoma/hepatoblastoma and metastatic colorectal cancer. There are 
no statistically significant differences between the two at any point of 
time. 
252 IWATSUKI, SHAW, AND STARZL Ann. Surg .• March 1983 
TABLE 5. Literature Survey of Operative Mortality and Long-term Survival After Liver Resection 
Survival 
No. of Operative 
Investigators Indications Patients Mortality I y 2y 3y 5 Y 
Foster's review7 Primary liver cancer 296 24.0% (A) 33.3% 14.0% 
Asian 24.0% (A) 23.0% 6.0% 
Non-Asian 22.0% (A) 59.0% 36.0% 
Foster's reviews Metastatic >400 11.0% (A) 
colorectal cancer 192 44.0% 22.0%* 
Lin9.10 Primary liver cancer 118 11.8% (B) 35.0%* 24.4%* 20.0%* 19.0%* 
Lee et al. 11 Primary liver cancer 165 20.0% (A) 45.0%t 30.0%t 20.0%t 20.0%t 
Joishy & BaJasegaram l2•13 Malignant and benign 288 11.8% (A) 
all malignancy 133 12.8% (A) 
primary liver carcinoma 94 14.9% (A) 
Wu et al. 14 Primary liver carcinoma 181 8.8% (B) 55.9%* 36.8%* 38.9%* 16.0%* 
Almersjo et al. 's All malignancy 46 30.0% (B) 31.0%* 
Smith 16 Primary liver malignancy 60 6.7% (D) 26.7% 
Bengmark et al. 17•18 Primary malignancy 21 14.3% (A) 47.6% 38.1% 
colorectal cancer 32 6.3% (B) 20-25%t 
Longmire et al. 19 Malignant and benign 75 9.3% (C) 
all malignancy 41 12.2% (C) 
primary liver malignancy 19 21.2% (C) 
Fortner et al.20.21 Malignant and benign 137 9.3% (B) 
all malignancy 113 10.6% (B) 
primary liver cancer 42 16.7% (B) 85.0%*t 50.0%*t 37.0%*t 
colorectal cancer 43 9.3% (B) 87.0%*t 
colorectal cancer 25 8.0% (B) 88.0%*t 48.0%*t 48.0%*t 
Adson & Weiland22 Primary liver neoplasm 60 6.7% (B) 65.0%*t 36.0%*t 
primary liver malignancy 46 4.3% (B) 
Wilson & Adson23 Colorectal cancer 60 1.7% (B) 28.0%*t 
Adson & Van Heerden24 Colorectal cancer 34 5.9% (B) 82.0%* 58.0%* 41.0%* 
Present Study Malignant and benign 150 4.0% (A & B) 
malignant tumors 86 4.7% (A & B) 
primary liver malignancy 43 9.3% (A & B) 77.8%t 59.5%t 55.7%t 46.0%t 
metastatic tumors 43 0.0% (A & B) 8S.3%t 66.7%t 66.7%t 57.2%t 
metastatic colorectal 24 0.0% (A & B) 91.3%t 73.0%t 73.0%t 52.I%t 
Definition of Operative Mortality: A = death in initial hospitaliza- * Operative death excluded. 
tion, B = death in 30 days, C = death in 60 days, D = intraoperative t Actuarial survival. 
death. 
were not determinant since not all of their patients could Fortner et al. reported one-, three-, and five-year actu-
be followed up. Wu et al. in Shaghai reported the largest arial survival of, respectively, 85%, 50%, and 37%, ex-
series from a single institution in 1980. 14 Their one- to cluding the patients who died perioperatively. Since their 
five-year actual survival rates were 55.9%, 36.8%,28.9%, operative mortality was 16.7%, the uncorrected one-, 
21.8% and 16%, excluding an 8.8% operative mortality. three- and five-year actuarial survival rate including per-
Seventy per cent of their patients had cirrhotic livers. ioperative deaths wold have been approximately 71 %, 
In Europe Almersjo, Bengmark, and Hafstr6m reported 42%, and 31 %, respectively.2o,21 Adson and Weiland re-
two-year actual survival of 31 %, excluding operative ported three- and five-year actuarial survival, respec-
mortality of 30%,15 and in 1979 Smith reported a 27% tively, of 65% and 36%, excluding operative deaths.22 
survival two years after resection. 16 In the United States Our one- to five-year uncorrected actuarial survivals, 
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respectively, of 77.8%, 59.5%,55.7%,46%, and 46% for 
primary liver malignancy, support the commonly held 
view that liver resection is the treatment of choice for 
primary liver malignancy. 
The results of liver resection for metastatic liver tu-
mors also have been encouraging, particularly since such 
resections can be performed with minimum mortality. 
Foster reviewed more than 400 hospital records of pa-
tients with metastatic liver tumor from colorectal cancer 
and reported in 1978 two- and five-year determinant 
survival, respectively, of 44% and 22%, excluding the 
patients who died during the initial hospitalization.8 
Fortner et al. reported one-, two-, and three-year actu-
arial survival of 88%, 48%, and 48% excluding an op-
erative mortality of 8%.20,21 Wilson and Adson reported 
a five-year survival of 28% among 60 patients with liver 
metastasis from colorectal cancer, two thirds of whom 
were treated by wedge resection of the liver.23 Later, 
Adson and Van Heerden reported one-, two-, and three-
year actual survival, respectively, of 82%, 58%, and 44% 
among 34 patients who had major hepatic resections 
excluding operative deaths.24 The authors have obtained 
one-, three-, and five-year actuarial survival, respec-
tively, of 91.3%, 73%, and 52.1 % in patients with met-
astatic colorectal cancer without any operative mortal-
ity. Although these survival figures seem to be higher 
than those of others, there is no statistically significant 
difference between them at present. If the higher survival 
figures hold for several more years, this may, at least 
partly, reflect the policy of extensive liver resections as 
opposed to local excision for metastatic tumors. 
After resection of both primary and metastatic neo-
plasms, the question of adjuvant therapy remains open. 
Even with the development of more effective chemo-
therapy, liver resection when possible for both primary 
and secondary malignant tumors should continue to be 
an important component of care. 
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